Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages

J Virol. 2019 May 15;93(11):e00020-19. doi: 10.1128/JVI.00020-19. Print 2019 Jun 1.

Abstract

HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in intracellular plasma membrane-connected structures termed virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The cellular restriction factor bone marrow stromal cell antigen 2 (BST2), which prevents HIV-1 dissemination by tethering budding viral particles at the plasma membrane, can be found in VCCs. The HIV-1 accessory protein Vpu counteracts the restriction factor BST2 by downregulating its expression and removing it from viral budding sites. Numerous studies described these Vpu countermeasures in CD4+ T cells or model cell lines, but the interplay between Vpu and BST2 in VCC formation and HIV-1 production in macrophages is less explored. Here, we show that Vpu expression in HIV-1-infected macrophages enhances viral release. This effect is related to Vpu's ability to circumvent BST2 antiviral activity. We show that in absence of Vpu, BST2 is enriched in VCCs and colocalizes with capsid p24, whereas Vpu expression significantly reduces the presence of BST2 in these compartments. Furthermore, our data reveal that BST2 is dispensable for the formation of VCCs and that Vpu expression impacts the volume of these compartments. This Vpu activity partly depends on BST2 expression and requires the integrity of the Vpu transmembrane domain, the dileucine-like motif E59XXXLV64 and phosphoserines 52 and 56 of Vpu. Altogether, these results highlight that Vpu controls the volume of VCCs and promotes HIV-1 release from infected macrophages.IMPORTANCE HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The restriction factor BST2, which prevents HIV-1 dissemination by tethering budding viral particles, can be found in VCCs. The HIV-1 Vpu protein counteracts BST2. This study explores the interplay between Vpu and BST2 in the viral protein functions on HIV-1 release and viral particle sequestration in VCCs in macrophages. The results show that Vpu controls the volume of VCCs and favors viral particle release. These Vpu functions partly depend on Vpu's ability to antagonize BST2. This study highlights that the transmembrane domain of Vpu and two motifs of the Vpu cytoplasmic domain are required for these functions. These motifs were notably involved in the control of the volume of VCCs by Vpu but were dispensable for the prevention of the specific accumulation of BST2 in these structures.

Keywords: BST2/tetherin; VCC; Vpu; human immunodeficiency virus; macrophage; restriction factor; vesicular trafficking; viral release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / metabolism
  • Bone Marrow Stromal Antigen 2 / metabolism
  • Cell Membrane / metabolism*
  • Cytoplasm / metabolism
  • GPI-Linked Proteins / genetics
  • GPI-Linked Proteins / metabolism
  • Gene Expression Regulation, Viral / genetics
  • HEK293 Cells
  • HIV Core Protein p24 / metabolism
  • HIV Infections / metabolism
  • HIV Infections / virology
  • HIV Seropositivity
  • HIV-1 / immunology
  • HIV-1 / metabolism
  • HIV-1 / pathogenicity
  • HeLa Cells
  • Human Immunodeficiency Virus Proteins / metabolism*
  • Human Immunodeficiency Virus Proteins / physiology
  • Humans
  • Macrophages / metabolism*
  • Macrophages / virology
  • Viral Regulatory and Accessory Proteins / metabolism*
  • Viral Regulatory and Accessory Proteins / physiology
  • Virion / metabolism
  • Virus Assembly / physiology
  • Virus Release / physiology

Substances

  • Antigens, CD
  • Bone Marrow Stromal Antigen 2
  • GPI-Linked Proteins
  • HIV Core Protein p24
  • Human Immunodeficiency Virus Proteins
  • Viral Regulatory and Accessory Proteins
  • vpu protein, Human immunodeficiency virus 1